Literature DB >> 15256217

Multiple oxidative stress-response members of the Adapt78 family.

Henry J Michtalik1, Ananth V Narayan, Nishant Bhatt, H Y Lin, Michael T Mulligan, Shen Li Zhang, Dana R Crawford.   

Abstract

Adapt78 is an oxidative and calcium stress-response gene. Its protein product is a potent natural inhibitor of the intracellular calcium signaling protein calcineurin. Much of what is known about Adapt78 protein is based on cell-transfection studies. Toward understanding natural endogenous Adapt78, we used an antibody raised against cellular Adapt78 and recently determined that endogenous Adapt78 protein, like its mRNA, is oxidative and calcium stress responsive. Here we report the identification of a second endogenous form of this protein family of 41 kDa. Subcellular fractionation of human HeLa cells revealed that in contrast to results of previous transfection studies, most endogenous Adapt78, characterized as 29 and 41 kDa electrophoretic doublets, resides in the cellular cytosol. The 41 kDa form of Adapt78 was abundant and found to exhibit many characteristics in common with the previously reported oxidative stress-responsive 29 kDa form, including hypo- and hyperphosphorylation variants, rapid loss of the hypophosphorylated form following oxidative stress, response to various kinase and phosphatase inhibitors, and localization. However, it also exhibited some unique characteristics, most notably the lack of calcium inducibility. Finally, the 29 kDa form exhibited a much shorter half-life and strong stabilization following oxidant exposure compared with the 41 kDa Adapt78 form. These data reveal the presence of a novel oxidative stress-responsive 41 kDa Adapt78 species, lend further insight into the Adapt78 family of proteins and their distribution, and challenge previous conclusions obtained using transfection protocols.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256217     DOI: 10.1016/j.freeradbiomed.2004.05.014

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Down syndrome critical region 1 enhances the proteolytic cleavage of calcineurin.

Authors:  Ji-Eun Lee; Hyonchol Jang; Eun-Jung Cho; Hong-Duk Youn
Journal:  Exp Mol Med       Date:  2009-07-31       Impact factor: 8.718

2.  Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation.

Authors:  Shazaan Hushmendy; Lalithapriya Jayakumar; Amy B Hahn; Devang Bhoiwala; Dipti L Bhoiwala; Dana R Crawford
Journal:  Nutr Res       Date:  2009-08       Impact factor: 3.315

Review 3.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Do RCAN1 proteins link chronic stress with neurodegeneration?

Authors:  Gennady Ermak; Melanie A Pritchard; Sladjana Dronjak; Brenda Niu; Kelvin J A Davies
Journal:  FASEB J       Date:  2011-06-16       Impact factor: 5.191

Review 5.  Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.

Authors:  Gennady Ermak; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2013-01-29       Impact factor: 7.376

Review 6.  The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development.

Authors:  E Torac; L Gaman; V Atanasiu
Journal:  J Med Life       Date:  2014 Oct-Dec

7.  Growth hormone increases regulator of calcineurin 1-4 (Rcan1-4) mRNA through c-JUN in rat liver.

Authors:  Tomoko Nakata; Yuka Toyoshima; Takashi Yagi; Harumi Katsumata; Reiko Tokita; Shiro Minami
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.